Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00182975 · ClinicalTrials.gov registry record · Phase 3
Effects of Dehydroepiandrosterone (DHEA) in Humans
A Phase 3 study, sponsored by National Institute on Aging (NIA).
- Completed
- Registry status
- Phase 3
- Development phase
- 142
- Enrollment target
NCT00182975 is a Phase 3 study that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 142 participants.
The verdict
NCT00182975, a Phase 3 study, has completed, sponsored by National Institute on Aging (NIA).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 142 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether bringing back the DHEA levels of older persons to the young range produces beneficial effects.
Interventions
- DRUG DHEA replacement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2002-09 |
| Est. Completion | 2007-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00182975
The ClinicalTrials.gov registry entry for NCT00182975 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 142 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Aging (NIA), which has 131 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DHEA replacement is the first listed.
NCT00182975 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00182975 about?
NCT00182975 is a clinical study titled "Effects of Dehydroepiandrosterone (DHEA) in Humans". The purpose of this study is to determine whether bringing back the DHEA levels of older persons to the young range produces beneficial effects.
What is the current status of trial NCT00182975?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 142 participants. The study started on 2002-09. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00182975?
The interventions under investigation include: DHEA replacement (DRUG).
Who is sponsoring clinical trial NCT00182975?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.